The Development Grants scheme provides financial support to individual researchers and/or research teams to undertake health and medical research within Australia at the proof-of-concept stage that specifically drives towards a commercial outcome within a foreseeable timeframe.
The Development Grants scheme supports the commercial development of a product, process, procedure or service that, if applied, would result in improved health care, disease prevention or provide health cost savings.
Research supported by this scheme must, via a commercial business plan, have detailed feasible strategies for commercialisation that take into account the regulatory pathway, protectable intellectual property, commercial barriers and potential routes to market.
The Development Grants scheme will not fund early stage research or knowledge creation research (this is fundable through the Ideas Grant scheme).
Peer Review Information
NHMRC has completed the planned pilot of conflict of interest and suitability declarations in Sapphire. The Development Grants Sapphire pilot is continuing with the launch of the Assessment module.
There have been changes to peer review process for the Development Grants 2020 round, including:
- Two additional reviewers (one scientific and one commercial) per application, therefore each application will be reviewed by up to 10 (5 scientific and 5 commercial) peer reviewers.
- Qualitative feedback will be provided to applicants.
- Grant Review Panel (GRP) meetings will no longer be held to discuss applications by exception.
- Peer reviewers will be able to seek clarification on peer review policies and processes during the assessment phase from an independent Chair.
For details regarding the Development Grants 2020 peer review process, please refer to the Development Grants 2020 Peer Review Guidelines available from the download section below.